Pulse Biosciences Inc EV / EBITDA
Was ist das EV / EBITDA von Pulse Biosciences Inc?
EV / EBITDA von Pulse Biosciences Inc ist N/A
Was ist die Definition von EV / EBITDA?
EV / EBITDA ist der Unternehmenswert geteilt durch das Einkommen vor Zinsen, Steuern, Abschreibungen und Amortisationen. Es ist ein Maß dafür, wie teuer eine Aktie ist und für Vergleiche zwischen Unternehmen häufiger gültig ist als das Preis-Gewinn-Verhältnis. Er misst den Preis (in Form des Unternehmenswerts), den ein Investor zu Gunsten des Cashflows des Unternehmens (in Form des EBITDA) bezahlt.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Pulse Biosciences Inc
Was macht Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Unternehmen mit ev / ebitda ähnlich Pulse Biosciences Inc
- Terramin Australia hat EV / EBITDA von N/A
- Danakali hat EV / EBITDA von N/A
- Prospect Park Capital hat EV / EBITDA von N/A
- Altura Mining hat EV / EBITDA von N/A
- Redstar Gold hat EV / EBITDA von N/A
- Aminex Plc hat EV / EBITDA von N/A
- Pulse Biosciences Inc hat EV / EBITDA von N/A
- Nova Cannabis hat EV / EBITDA von N/A
- GT Gold hat EV / EBITDA von N/A
- Nanoxplore Inc hat EV / EBITDA von N/A
- Cervantes hat EV / EBITDA von N/A
- SolGold Plc hat EV / EBITDA von N/A
- Sailfish Royalty hat EV / EBITDA von N/A